亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Comparison of The Efficacy and Safety of Sertraline, Reboxetine, and Venlafaxine in Patients with Major Depressive Disorder: A Pooled Analysis of Four Randomized, Open-Label Trials

作者
Cengiz Akkaya,Selçuk Kırlı,Salih Saygın Eker,Şengül Cangür,Mustafa Canbazoglu,Aslı Sarandöl
出处
期刊:Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology [Taylor & Francis]
卷期号:20 (4): 274-287 被引量:2
标识
DOI:10.1080/10177833.2010.11790673
摘要

Objective: This paper aims to compare the efficacy and safety of three widely used antidepressants, sertraline, reboxetine, a sertraline-reboxetine combination and venlafaxine, in the treatment of MDD and their effect on depressive symptoms in MDD patients.Methods: A total of 206 patients were included in reboxetine, venlafaxine, sertraline, and sertraline-reboxetine combination groups; however 37 cases dropped out during the study period. The remaining 169 patients were distributed to groups as follows: reboxetine: 43, venlafaxine: 43, sertraline 42, sertraline-reboxetine combination group: 41. The data from patients, who were included and completed the previous four open-label studies, were pooled in the current study.Results: Treatment groups did not differ in terms of depression-related and sociodemographic features. There were no significant differences among treatment groups in terms of efficacy, safety, and remission. The reductions in HDRS scores as percentages were higher in venlafaxine group compared to sertraline group at visit 2 and visit 3 [p=0.001, ES: 0.1404 (large) and p=0.002, ES: 0.1109 (medium), respectively] and to the sertraline-reboxetine combination group at visit 2 and visit 3 [p=0.006, ES: 0.0910 (medium) and p=0.004, ES: 0.1023 (medium), respectively]. In addition, percentage changes of HDRS scores were higher in the reboxetine group compared to sertraline group at visit 2 [p=0.023, ES: 0.0615 (medium)]. HDRS items 1, 7, 10, 11, 13, and 14 formed the total HDRS score of all patients in remission.Conclusions: The antidepressants acting through different neurotransmitter systems display similar efficacy, though they are effective on different depressive symptoms or symptom clusters. Those treatment strategies also differed from each other in terms of onset of antidepressant efficacy. Despite its limitations, due to the lack of studies on this issue in the literature, the present stuydy is a valuable preliminary study.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
勤劳晋鹏完成签到,获得积分10
2秒前
重要静柏完成签到,获得积分10
4秒前
5秒前
笑点低的咖啡完成签到,获得积分10
5秒前
null的应助被teyr采纳,获得10
8秒前
彭于晏的应助被笑点低的咖啡采纳,获得10
9秒前
christy完成签到,获得积分20
13秒前
15秒前
null的应助被teyr采纳,获得10
17秒前
21秒前
Owen的应助被小黑桃采纳,获得10
31秒前
嘻嘻哈哈的应助被科研通管家采纳,获得10
32秒前
JamesPei的应助被科研通管家采纳,获得10
32秒前
null的应助被科研通管家采纳,获得20
32秒前
null的应助被科研通管家采纳,获得10
32秒前
香蕉觅云的应助被科研通管家采纳,获得10
33秒前
34秒前
39秒前
44秒前
waui完成签到 ,获得积分10
45秒前
51秒前
小巧的寒烟完成签到,获得积分10
51秒前
Rain完成签到,获得积分20
51秒前
Rain发布了新的文献求助10
55秒前
无极微光的应助被难过花瓣采纳,获得20
55秒前
55秒前
1分钟前
眼中星光完成签到,获得积分10
1分钟前
1分钟前
cc对应助文件撤销了驳回
1分钟前
1分钟前
停騮_ 完成签到,获得积分10
1分钟前
搜集达人的应助被锅包肉采纳,获得10
1分钟前
危机的奄完成签到,获得积分10
1分钟前
成就书雪完成签到,获得积分0
1分钟前
1分钟前
哇二木耶完成签到,获得积分10
1分钟前
1分钟前
hogjluo完成签到,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165954
求助须知:如何正确求助?哪些是违规求助? 9559332
关于积分的说明 21749951
捐赠科研通 7756726
什么是DOI,文献DOI怎么找? 3429092
关于科研通互助平台的介绍 2553386
邀请新用户注册赠送积分活动 2473657